These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 23481110)
21. Microbiological diagnosis and antibiotic therapy in patients with community-acquired pneumonia and acute COPD exacerbation in daily clinical practice: comparison to current guidelines. Reissig A; Mempel C; Schumacher U; Copetti R; Gross F; Aliberti S Lung; 2013 Jun; 191(3):239-46. PubMed ID: 23564195 [TBL] [Abstract][Full Text] [Related]
22. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood]. Ouchi K Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086 [TBL] [Abstract][Full Text] [Related]
23. [A comparison of moxifloxacin and amoxicillin in the treatment of community-acquired pneumonia in Latin America: results of a multicenter clinical trial]. Jardim JR; Rico G; de la Roza C; Obispo E; Urueta J; Wolff M; Miravitlles M; Arch Bronconeumol; 2003 Sep; 39(9):387-93. PubMed ID: 12975069 [TBL] [Abstract][Full Text] [Related]
24. The correct approach to community-acquired pneumonia in immunocompetent adults: review of current guidelines. Carbonara S; Stano F; Scotto G; Monno L; Angarano G New Microbiol; 2008 Jan; 31(1):1-18. PubMed ID: 18437837 [TBL] [Abstract][Full Text] [Related]
25. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Lim WS; Macfarlane JT; Boswell TC; Harrison TG; Rose D; Leinonen M; Saikku P Thorax; 2001 Apr; 56(4):296-301. PubMed ID: 11254821 [TBL] [Abstract][Full Text] [Related]
26. Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia. Lui G; Ip M; Lee N; Rainer TH; Man SY; Cockram CS; Antonio GE; Ng MH; Chan MH; Chau SS; Mak P; Chan PK; Ahuja AT; Sung JJ; Hui DS Respirology; 2009 Nov; 14(8):1098-105. PubMed ID: 19818051 [TBL] [Abstract][Full Text] [Related]
27. Community-Acquired Pneumonia in the Asia-Pacific Region. Song JH; Huh K; Chung DR Semin Respir Crit Care Med; 2016 Dec; 37(6):839-854. PubMed ID: 27960208 [TBL] [Abstract][Full Text] [Related]
28. Community-acquired pneumonia in children. Dennehy PH Med Health R I; 2010 Jul; 93(7):211-5. PubMed ID: 20704068 [No Abstract] [Full Text] [Related]
29. [ALAT (Latin American Thoracic Association) recommendations on community-acquired pneumonia]. Luna CM; Ramírez J; López H; Mazzei JA; Abreu de Oliveira JC; Pereira J; Jardim JR; Gonzáles P; Lisboa C; Maldonado D; Torres C; Martínez Selmo S; Miravitlles M; Rodríguez de Castro F; Torres A; Anzueto A; Luna JM; Diaz M; Pérez Padilla R; Sansores R; Arch Bronconeumol; 2001 Sep; 37(8):340-8. PubMed ID: 11562320 [No Abstract] [Full Text] [Related]
30. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review. Mathur S; Fuchs A; Bielicki J; Van Den Anker J; Sharland M Paediatr Int Child Health; 2018 Nov; 38(sup1):S66-S75. PubMed ID: 29790844 [TBL] [Abstract][Full Text] [Related]
31. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore. Chiang WC; Teoh OH; Chong CY; Goh A; Tang JP; Chay OM Respirology; 2007 Mar; 12(2):254-61. PubMed ID: 17298459 [TBL] [Abstract][Full Text] [Related]
36. Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial. Bielicki JA; Stöhr W; Barratt S; Dunn D; Naufal N; Roland D; Sturgeon K; Finn A; Rodriguez-Ruiz JP; Malhotra-Kumar S; Powell C; Faust SN; Alcock AE; Hall D; Robinson G; Hawcutt DB; Lyttle MD; Gibb DM; Sharland M; JAMA; 2021 Nov; 326(17):1713-1724. PubMed ID: 34726708 [TBL] [Abstract][Full Text] [Related]
37. The aetiology of community-acquired pneumonia and implications for patient management. van Gageldonk-Lafeber AB; Wever PC; van der Lubben IM; de Jager CP; Meijer A; de Vries MC; Elberse K; van der Sande MA; van der Hoek W Neth J Med; 2013 Oct; 71(8):418-25. PubMed ID: 24127502 [TBL] [Abstract][Full Text] [Related]
38. Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance. Rapp RP Postgrad Med; 2002 Sep; 112(3 Suppl):12-7. PubMed ID: 19667590 [TBL] [Abstract][Full Text] [Related]
39. Relevance of healthcare-associated pneumonia for empirical antibiotic therapy in the Netherlands. Schweitzer VA; van Werkhoven CH; van Heijl I; Smits RF; Boel CHE; Bonten MJM; Postma DF; Oosterheert JJ Neth J Med; 2018 Nov; 76(9):389-396. PubMed ID: 30465653 [TBL] [Abstract][Full Text] [Related]
40. Azithromycin plus β-lactam versus levofloxacin plus β-lactam for severe community-acquired pneumonia: A retrospective nationwide database analysis. Suzuki J; Sasabuchi Y; Hatakeyama S; Matsui H; Sasahara T; Morisawa Y; Yamada T; Yasunaga H J Infect Chemother; 2019 Dec; 25(12):1012-1018. PubMed ID: 31227381 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]